Skip to main content
Erschienen in: Annals of Surgical Oncology 6/2015

01.06.2015 | Gynecologic Oncology

Success Factors of Laparoscopic Nerve-sparing Radical Hysterectomy for Preserving Bladder Function in Patients with Cervical Cancer: A Protocol-Based Prospective Cohort Study

verfasst von: Hee Seung Kim, MD, Tae Hun Kim, MD, Dong Hoon Suh, MD, Sang Youn Kim, MD, Min A. Kim, MD, PhD, Chang Wook Jeong, MD, PhD, Kyoung Sup Hong, MD, Yong Sang Song, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Success factors of laparoscopic nerve-sparing radical hysterectomy (LNRH) to preserve bladder function are little known despite its widespread use. Thus, we conducted a protocol-based prospective cohort study to evaluate clinicopathologic factors for preserving autonomic nerves and its impact on duration of postoperative catheterization (DPC).

Methods

From 2012 to 2014, 30 patients with stage IB1 to IIA2 cervical cancer were recruited prospectively to undergo LNRH. All procedures were performed on the left side of the patients by one gynecologic oncologist. Extent of resection and preservation of autonomic nerves were documented in the protocol during LNRH.

Results

All patients received laparoscopic type C1 radical hysterectomy, where extent of resection and preservation of autonomic nerves were not different between the right and left sides. Stage IB1 disease was associated with the reduced risk of injury of the left junctions between the hypogastric and the splanchnic nerves; between the splanchnic nerve and the vesical branch of the pelvic plexus (S–V junction) (adjusted odds ratios, 0.06 and 0.06; 95 % confidence intervals, 0.01–0.92 and 0.01–0.48); the right S–V junction with marginal significance (adjusted odds ratio, 0.18; 95 % confidence interval, 0.03–1.06). Furthermore, bilateral preservation of autonomic nerves decreased DPC significantly when compared with failure or unilateral preservation (median, 6 days vs. 34 days or 57 days; P < 0.05).

Conclusions

LNRH has a higher likelihood of its success in stage IB1 than in stage IB2 to IIA disease. Moreover, preservation of bilateral autonomic nerves reduces DPC significantly in comparison with failure or unilateral preservation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Hockel M, Horn LC, Manthey N, et al. Resection of the embryologically defined uterovaginal (Mullerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis. Lancet Oncol. 2009;10:683–92.CrossRefPubMed Hockel M, Horn LC, Manthey N, et al. Resection of the embryologically defined uterovaginal (Mullerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis. Lancet Oncol. 2009;10:683–92.CrossRefPubMed
3.
Zurück zum Zitat Hockel M, Hentschel B, Horn LC. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis. Lancet Oncol. 2014;15:445–56.CrossRefPubMed Hockel M, Hentschel B, Horn LC. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis. Lancet Oncol. 2014;15:445–56.CrossRefPubMed
4.
Zurück zum Zitat Lee TY, Jeung YJ, Lee CJ, et al. Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer. Obstet Gynecol Sci. 2013;56:15–21.CrossRefPubMedCentralPubMed Lee TY, Jeung YJ, Lee CJ, et al. Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer. Obstet Gynecol Sci. 2013;56:15–21.CrossRefPubMedCentralPubMed
5.
Zurück zum Zitat Kim HS, Kim JY, Park NH, et al. Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1–IIA cervical cancer. Gynecol Oncol. 2010;119:217–24.CrossRefPubMed Kim HS, Kim JY, Park NH, et al. Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1–IIA cervical cancer. Gynecol Oncol. 2010;119:217–24.CrossRefPubMed
6.
Zurück zum Zitat Quinn MA, Benedet JL, Odicino F, et al. Carcinoma of the cervix uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S43–103.CrossRefPubMed Quinn MA, Benedet JL, Odicino F, et al. Carcinoma of the cervix uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S43–103.CrossRefPubMed
7.
Zurück zum Zitat Suh DH, Kim JW, Kang S, et al. Major clinical research advances in gynecologic cancer in 2013. J Gynecol Oncol. 2014;25:236–48. Suh DH, Kim JW, Kang S, et al. Major clinical research advances in gynecologic cancer in 2013. J Gynecol Oncol. 2014;25:236–48.
8.
Zurück zum Zitat Benedetti-Panici P, Zullo MA, Plotti F, et al. Long-term bladder function in patients with locally advanced cervical carcinoma treated with neoadjuvant chemotherapy and type 3–4 radical hysterectomy. Cancer. 2004;100:2110–7.CrossRefPubMed Benedetti-Panici P, Zullo MA, Plotti F, et al. Long-term bladder function in patients with locally advanced cervical carcinoma treated with neoadjuvant chemotherapy and type 3–4 radical hysterectomy. Cancer. 2004;100:2110–7.CrossRefPubMed
9.
Zurück zum Zitat Chen GD, Lin LY, Wang PH, Lee HS. Urinary tract dysfunction after radical hysterectomy for cervical cancer. Gynecol Oncol. 2002;85:292–7.CrossRefPubMed Chen GD, Lin LY, Wang PH, Lee HS. Urinary tract dysfunction after radical hysterectomy for cervical cancer. Gynecol Oncol. 2002;85:292–7.CrossRefPubMed
10.
Zurück zum Zitat Zullo MA, Manci N, Angioli R, et al. Vesical dysfunctions after radical hysterectomy for cervical cancer: a critical review. Crit Rev Oncol Hematol. 2003;48:287–93.CrossRefPubMed Zullo MA, Manci N, Angioli R, et al. Vesical dysfunctions after radical hysterectomy for cervical cancer: a critical review. Crit Rev Oncol Hematol. 2003;48:287–93.CrossRefPubMed
11.
Zurück zum Zitat Pieterse QD, Kenter GG, Maas CP, et al. Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study. Int J Gynecol Cancer. 2013;23:1717–25.CrossRefPubMed Pieterse QD, Kenter GG, Maas CP, et al. Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study. Int J Gynecol Cancer. 2013;23:1717–25.CrossRefPubMed
12.
Zurück zum Zitat Possover M, Stober S, Plaul K, Schneider A. Identification and preservation of the motoric innervation of the bladder in radical hysterectomy type III. Gynecol Oncol. 2000;79:154–7.CrossRefPubMed Possover M, Stober S, Plaul K, Schneider A. Identification and preservation of the motoric innervation of the bladder in radical hysterectomy type III. Gynecol Oncol. 2000;79:154–7.CrossRefPubMed
13.
Zurück zum Zitat Querleu D, Narducci F, Poulard V, et al. Modified radical vaginal hysterectomy with or without laparoscopic nerve-sparing dissection: a comparative study. Gynecol Oncol. 2002;85:154–8.CrossRefPubMed Querleu D, Narducci F, Poulard V, et al. Modified radical vaginal hysterectomy with or without laparoscopic nerve-sparing dissection: a comparative study. Gynecol Oncol. 2002;85:154–8.CrossRefPubMed
14.
Zurück zum Zitat Ceccaroni M, Roviglione G, Spagnolo E, et al. Pelvic dysfunctions and quality of life after nerve-sparing radical hysterectomy: a multicenter comparative study. Anticancer Res. 2012;32:581–8.PubMed Ceccaroni M, Roviglione G, Spagnolo E, et al. Pelvic dysfunctions and quality of life after nerve-sparing radical hysterectomy: a multicenter comparative study. Anticancer Res. 2012;32:581–8.PubMed
15.
Zurück zum Zitat Bogani G, Cromi A, Uccella S, et al. Nerve-sparing versus conventional laparoscopic radical hysterectomy: a minimum 12 months’ follow-up study. Int J Gynecol Cancer. 2014;24:787–93.CrossRefPubMed Bogani G, Cromi A, Uccella S, et al. Nerve-sparing versus conventional laparoscopic radical hysterectomy: a minimum 12 months’ follow-up study. Int J Gynecol Cancer. 2014;24:787–93.CrossRefPubMed
16.
Zurück zum Zitat Fujii S. Anatomic identification of nerve-sparing radical hysterectomy: a step-by-step procedure. Gynecol Oncol. 2008;111:S33–41.CrossRefPubMed Fujii S. Anatomic identification of nerve-sparing radical hysterectomy: a step-by-step procedure. Gynecol Oncol. 2008;111:S33–41.CrossRefPubMed
17.
Zurück zum Zitat Dursun P, Ayhan A, Kuscu E. Nerve-sparing radical hysterectomy for cervical carcinoma. Crit Rev Oncol Hematol. 2009;70:195–205.CrossRefPubMed Dursun P, Ayhan A, Kuscu E. Nerve-sparing radical hysterectomy for cervical carcinoma. Crit Rev Oncol Hematol. 2009;70:195–205.CrossRefPubMed
18.
Zurück zum Zitat Querleu D, Morrow CP. Classification of radical hysterectomy. Lancet Oncol. 2008;9:297–303.CrossRefPubMed Querleu D, Morrow CP. Classification of radical hysterectomy. Lancet Oncol. 2008;9:297–303.CrossRefPubMed
19.
Zurück zum Zitat Raspagliesi F, Ditto A, Fontanelli R, et al. Type II versus type III nerve-sparing radical hysterectomy: comparison of lower urinary tract dysfunctions. Gynecol Oncol. 2006;102:256–62.CrossRefPubMed Raspagliesi F, Ditto A, Fontanelli R, et al. Type II versus type III nerve-sparing radical hysterectomy: comparison of lower urinary tract dysfunctions. Gynecol Oncol. 2006;102:256–62.CrossRefPubMed
20.
Zurück zum Zitat Rob L, Halaska M, Robova H. Nerve-sparing and individually tailored surgery for cervical cancer. Lancet Oncol. 2010;11:292–301.CrossRefPubMed Rob L, Halaska M, Robova H. Nerve-sparing and individually tailored surgery for cervical cancer. Lancet Oncol. 2010;11:292–301.CrossRefPubMed
21.
Zurück zum Zitat Charoenkwan K, Pranpanas S. Prevalence and characteristics of late postoperative voiding dysfunction in early-stage cervical cancer patients treated with radical hysterectomy. Asian Pac J Cancer Prev. 2007;8:387–9.PubMed Charoenkwan K, Pranpanas S. Prevalence and characteristics of late postoperative voiding dysfunction in early-stage cervical cancer patients treated with radical hysterectomy. Asian Pac J Cancer Prev. 2007;8:387–9.PubMed
22.
Zurück zum Zitat Bergmark K, Avall-Lundqvist E, Dickman PW, et al. Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med. 1999;340:1383–9.CrossRefPubMed Bergmark K, Avall-Lundqvist E, Dickman PW, et al. Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med. 1999;340:1383–9.CrossRefPubMed
23.
Zurück zum Zitat Kim HS, Choi CH, Lim MC, et al. Safe criteria for less radical trachelectomy in patients with early-stage cervical cancer: a multicenter clinicopathologic study. Ann Surg Oncol. 2012;19:1973–9.CrossRefPubMed Kim HS, Choi CH, Lim MC, et al. Safe criteria for less radical trachelectomy in patients with early-stage cervical cancer: a multicenter clinicopathologic study. Ann Surg Oncol. 2012;19:1973–9.CrossRefPubMed
24.
Zurück zum Zitat Landoni F, Maneo A, Cormio G, et al. Class II versus class III radical hysterectomy in stage IB–IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80:3–12.CrossRefPubMed Landoni F, Maneo A, Cormio G, et al. Class II versus class III radical hysterectomy in stage IB–IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80:3–12.CrossRefPubMed
25.
Zurück zum Zitat van den Tillaart SA, Kenter GG, Peters AA, et al. Nerve-sparing radical hysterectomy: local recurrence rate, feasibility, and safety in cervical cancer patients stage IA to IIA. Int J Gynecol Cancer. 2009;19:39–45.CrossRefPubMed van den Tillaart SA, Kenter GG, Peters AA, et al. Nerve-sparing radical hysterectomy: local recurrence rate, feasibility, and safety in cervical cancer patients stage IA to IIA. Int J Gynecol Cancer. 2009;19:39–45.CrossRefPubMed
26.
Zurück zum Zitat Kato K, Suzuka K, Osaki T, Tanaka N. Unilateral or bilateral nerve-sparing radical hysterectomy: a surgical technique to preserve the pelvic autonomic nerves while increasing radicality. Int J Gynecol Cancer. 2007;17:1172–8.CrossRefPubMed Kato K, Suzuka K, Osaki T, Tanaka N. Unilateral or bilateral nerve-sparing radical hysterectomy: a surgical technique to preserve the pelvic autonomic nerves while increasing radicality. Int J Gynecol Cancer. 2007;17:1172–8.CrossRefPubMed
27.
Zurück zum Zitat Tseng CJ, Shen HP, Lin YH, et al. A prospective study of nerve-sparing radical hysterectomy for uterine cervical carcinoma in Taiwan. Taiwan J Obstet Gynecol. 2012;51:55–9.CrossRefPubMed Tseng CJ, Shen HP, Lin YH, et al. A prospective study of nerve-sparing radical hysterectomy for uterine cervical carcinoma in Taiwan. Taiwan J Obstet Gynecol. 2012;51:55–9.CrossRefPubMed
28.
Zurück zum Zitat Liang JT, Chien CT, Chang KJ, et al. Neurophysiological basis of sympathetic nerve-preserving surgery for lower rectal cancer—a canine model. Hepatogastroenterology. 1998;45:2206–14.PubMed Liang JT, Chien CT, Chang KJ, et al. Neurophysiological basis of sympathetic nerve-preserving surgery for lower rectal cancer—a canine model. Hepatogastroenterology. 1998;45:2206–14.PubMed
29.
Zurück zum Zitat Chen C, Li W, Li F, et al. Classical and nerve-sparing radical hysterectomy: an evaluation of the nerve trauma in cardinal ligament. Gynecol Oncol. 2012;125:245–51.CrossRefPubMed Chen C, Li W, Li F, et al. Classical and nerve-sparing radical hysterectomy: an evaluation of the nerve trauma in cardinal ligament. Gynecol Oncol. 2012;125:245–51.CrossRefPubMed
30.
Zurück zum Zitat Ditto A, Martinelli F, Mattana F, et al. Class III nerve-sparing radical hysterectomy versus standard class III radical hysterectomy: an observational study. Ann Surg Oncol. 2011;18:3469–78.CrossRefPubMed Ditto A, Martinelli F, Mattana F, et al. Class III nerve-sparing radical hysterectomy versus standard class III radical hysterectomy: an observational study. Ann Surg Oncol. 2011;18:3469–78.CrossRefPubMed
32.
Zurück zum Zitat Ditto A, Martinelli F, Ramondino S, et al. Class II versus class III radical hysterectomy in early cervical cancer: an observational study in a tertiary center. Eur J Surg Oncol. 2014;40:883–90.CrossRefPubMed Ditto A, Martinelli F, Ramondino S, et al. Class II versus class III radical hysterectomy in early cervical cancer: an observational study in a tertiary center. Eur J Surg Oncol. 2014;40:883–90.CrossRefPubMed
Metadaten
Titel
Success Factors of Laparoscopic Nerve-sparing Radical Hysterectomy for Preserving Bladder Function in Patients with Cervical Cancer: A Protocol-Based Prospective Cohort Study
verfasst von
Hee Seung Kim, MD
Tae Hun Kim, MD
Dong Hoon Suh, MD
Sang Youn Kim, MD
Min A. Kim, MD, PhD
Chang Wook Jeong, MD, PhD
Kyoung Sup Hong, MD
Yong Sang Song, MD, PhD
Publikationsdatum
01.06.2015
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 6/2015
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-4197-1

Weitere Artikel der Ausgabe 6/2015

Annals of Surgical Oncology 6/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.